Sage Therapeutics ( NASDAQ:SAGE – Get Rating ) issued its earnings results on Tuesday. The biopharmaceutical company reported ($2.46) earnings per share for the quarter, beating analysts' consensus estimates of ($2.50) by $0.04, Briefing.com reports. Sage Therapeutics had a negative return on equity of 42.32% and a negative net margin of 5,932.09%. The firm had revenue of $3.30 million for the quarter, compared to analysts' expectations of $2.28 million. During the same quarter last year, the firm earned ($2.

https://www.dailypolitical.com/2023/05/05/sage-therapeutics-nasdaqsage-issues-earnings-results-beats-estimates-by-0-04-eps.html

#dailypolitical